Work Schedule
Rotational shift daysEnvironmental Conditions
Able to lift 40 lbs. without assistance, Adherence to all Good Manufacturing Practices (GMP) Safety Standards, Cold Room/Freezers -22degreesF/-6degrees C, Laboratory Setting, Some degree of PPE (Personal Protective Equipment) required (safety glasses, gowning, gloves, lab coat, ear plugs etc.), Standing for full shift, Will work with hazardous/toxic materialsJob Description
Q C Scientist
2 shift rotation 6am - 2.30pm / 2.00 pm - 10.30pm Monday to Friday
Microbiology QC Scientist (Band 4)
Position Summary
We are seeking a motivated and detail-oriented Microbiology Scientist to join our Quality Control team in Perth. Reporting to the Quality Control Team Leader – Microbiology, you will play a key role in ensuring the quality and safety of our microbiological media products through the testing and examination of bottled and plated media.
Our laboratory processes approximately 1,500 batches per month of plated agar and bottled media and operates to internationally recognised standards, including UKAS-accredited ISO 17025 testing procedures, alongside methodologies such as CEN, ISO 6222, EUCAST, and CLSI. This is an excellent opportunity to work within a highly regulated laboratory environment that supports quality, innovation, and continuous improvement.
About the Role
As a QC Scientist, you will be responsible for the sampling, testing, analysis, and reporting of quality control results for plated and bottled products. You will ensure testing is performed accurately, efficiently, and in compliance with regulatory and quality standards.
Key Responsibilities
About You
To be successful in this role, you will ideally have:
Thermo Fisher Scientific recently announced that it has entered into an agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm with deep expertise in healthcare, focused on a select set of subsectors, including pharmaceutical services and technology, medtech and related services, life science tools and diagnostics.
This decision follows a thoughtful evaluation as part of Thermo Fisher’s ongoing business strategy to actively manage and strengthen our portfolio.
We expect the transaction will be completed in the second half of 2026, subject to customary closing conditions and applicable regulatory approvals. Until the transaction is complete, Thermo Fisher will continue to operate the business.
If you join the microbiology business prior to the close of the transaction, your employment is expected to transition to Astorg.
For more information, please review:
Thermo Fisher’s press release
Astorg press release
Sign in to browse authentic reviews, anonymous ratings and salary data before you apply.